In this Innovation Spotlight, Dan Levangie, president and chief executive officer of CereVasc, discusses a new treatment strategy for NPH using an endovascularly implantable CSF shunt that minimizes ...
Hydrocephalus is an excess of cerebrospinal fluid (CSF) in the brain’s ventricles. Surgery is the first-line and most effective treatment. The two primary surgeries are the Ventriculoperitoneal (VP) ...
A landmark randomized, placebo-controlled trial provides the clearest evidence to date that shunt surgery benefits patients with idiopathic normal-pressure hydrocephalus (iNPH), a condition long ...
When music legend Billy Joel revealed that he had been diagnosed with normal pressure hydrocephalus (NPH) in 2025, he did more than share a personal health update—he shed light on a little-known but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback